Our Pipeline: Gastrointestinal Cancer Focus

The Value of Prophylactic Cancer Vaccines: "Imagine living without fear of cancer ever returning."

Imagine completing a cancer treatment cycle but still exhibiting minimal residual disease (MRD). This is a mentally debilitating experience often too common in cancer patients. EV Therapeutics is also developing a revolutionary new prophylactic (preventative) cancer vaccine based on our modified tumor-derived extracellular vesicles (mTEVs) platform that helps strengthen the patient's immune system to the level where cancer cells are kept in check and can no longer grow nor metastasize (i.e. spread to other organs and tissues). This innovative therapy may help to alleviate the fear and anxiety in the minds of millions of cancer survivors suffering with residual cancers after the initial surgical tumor resection is long forgotten.